|     | 研究者情報 | 
| ササキ ヒデオ
            SASAKI HIDEO 佐々木秀郎 所属 医学部医学科 腎泌尿器外科学 職種 客員教授 | |
| 論文種別 | 原著 | 
| 言語種別 | 英語 | 
| 査読の有無 | 査読あり | 
| 表題 | Single-cell analysis reveals a preexisting drug-resistant subpopulation in the luminal breast cancer subtype. | 
| 掲載誌名 | 正式名:Cancer research 略 称:Cancer Res ISSNコード:1538744500085472 | 
| 掲載区分 | 国外 | 
| 巻・号・頁 | 79(17),4412-4425頁 | 
| 著者・共著者 | Prieto-Vila Marta, Usuba Wataru, Takahashi Ryou-U, Shimomura Iwao, Sasaki Hideo, Ochiya Takahiro, Yamamoto Yusuke | 
| 発行年月 | 2019/09 | 
| 概要 | Drug resistance is a major obstacle in the treatment of breast cancer. Surviving cells lead to tumor recurrence and metastasis, which remains the main cause of cancer-related mortality. Breast cancer is also highly heterogeneous, which hinders the identification of individual cells with the capacity to survive anticancer treatment. To address this, we performed extensive single-cell gene-expression profiling of the luminal-type breast cancer cell line MCF7 and its derivatives, including docetaxel-resistant cells. Upregulation of epithelial-to-mesenchymal transition and stemness-related genes and downregulation of cell-cycle-related genes, which were mainly regulated by LEF1, were observed in the drug-resistant cells. Interestingly, a small number of cells in the parental population exhibited a gene-expression profile similar to that of the drug-resistant cells, indicating that the untreated parental cells already contained a rare subpopulation of stem-like cells with an inherent predisposition toward docetaxel resistance. Our data suggest that during chemotherapy, this population may be positively selected, leading to treatment failure. SIGNIFICANCE: This study highlights the role of breast cancer intratumor heterogeneity in drug resistance at a single-cell level. | 
| DOI | 10.1158/0008-5472.CAN-19-0122 | 
| PMID | 31289135 |